# SUPT4H1

## Overview
SUPT4H1 is a gene that encodes the SPT4 homolog, a protein subunit of the DSIF (DRB Sensitivity-Inducing Factor) elongation factor complex, which is integral to the regulation of transcription elongation by RNA polymerase II. The SPT4 homolog is categorized as a transcription elongation factor and plays a pivotal role in modulating the transition from transcription initiation to elongation, thereby influencing gene expression and cellular function. The protein's structural features, including its ability to form complexes with other proteins such as SUPT5H, are essential for its function in stabilizing the transcription machinery. SUPT4H1's involvement in transcriptional regulation is critical for maintaining cellular homeostasis and has significant implications in various biological processes, including development and stress response. Furthermore, alterations in SUPT4H1 expression have been linked to neurodegenerative disorders, highlighting its potential as a therapeutic target (Furuta2019Suppression; Park2022SUPT4H1edited; Wen2019The).

## Structure
The SUPT4H1 gene encodes the SPT4 homolog, a subunit of the DSIF elongation factor complex, which plays a crucial role in transcription regulation. The protein structure of SUPT4H1 includes primary sequences of amino acids that form the basis for its function. Its secondary structure is characterized by the presence of alpha helices and beta sheets, which contribute to the protein's stability and interaction capabilities. The tertiary structure involves the folding patterns that allow SUPT4H1 to achieve its functional conformation, essential for its role in transcription regulation.

SUPT4H1 may also participate in quaternary structures through interactions with other proteins, forming complexes that are vital for its function as part of the DSIF elongation factor. Post-translational modifications can influence the protein's function and stability, potentially affecting its interaction with other molecular components. Additionally, splice variant isoforms of SUPT4H1 may exist, which could lead to variations in its functional properties and regulatory roles. These structural features and modifications are integral to the protein's ability to regulate transcription effectively.

## Function
SUPT4H1 encodes a protein that is a component of the DSIF (DRB Sensitivity-Inducing Factor) complex, which plays a critical role in transcription elongation by RNA polymerase II. This complex is involved in regulating gene expression by modulating the transition from transcription initiation to elongation, a process essential for proper gene expression and cellular function (Wen2019The). SUPT4H1, as part of the DSIF complex, works in conjunction with the negative elongation factor (NELF) to regulate RNA polymerase II activity through promoter-proximal pausing. This pausing can be overcome by the positive transcription elongation factor b (P-TEFb) complex, highlighting SUPT4H1's role in fine-tuning transcriptional responses (Wen2019The).

In healthy human cells, SUPT4H1 is active in the nucleus, where it influences various cellular processes, including development and response to stress. Its function is crucial for maintaining normal cellular activities and ensuring the fidelity of transcriptional elongation (Hentges2004Comparative). The protein's involvement in transcriptional regulation underscores its importance in cellular homeostasis and the proper execution of genetic programs necessary for organismal development and function.

## Clinical Significance
The SUPT4H1 gene has been implicated in several neurodegenerative disorders due to its role in transcription elongation. In Huntington's disease (HD), a severe neurodegenerative disorder caused by CAG repeat expansions in the huntingtin gene (HTT), alterations in SUPT4H1 expression have shown therapeutic potential. Research indicates that SUPT4H1 gene editing can reduce mutant HTT expression without affecting wild-type HTT levels, which is crucial for maintaining normal physiological functions. This selective reduction of mutant HTT expression has been associated with improved motor function and neuronal differentiation in HD models, suggesting that SUPT4H1 could be a promising target for gene therapy in HD (Park2022SUPT4H1edited).

Additionally, the suppression of SUPT4H1 orthologs has been explored in the context of other repeat expansion disorders, such as spinocerebellar ataxia type 36 (SCA36). Studies have shown that targeting transcriptional elongation factors like SUPT4H1 can reduce RNA foci and cytotoxicity associated with these disorders, highlighting its potential as a therapeutic strategy (Furuta2019Suppression). These findings underscore the clinical significance of SUPT4H1 in managing diseases characterized by expanded repeat sequences.

## Interactions
SUPT4H1, also known as SPT4 homolog, is a component of the DSIF (DRB Sensitivity-Inducing Factor) complex, which plays a crucial role in transcription elongation. It forms a complex with SUPT5H, known as the Spt4/Spt5 complex, which interacts with RNA polymerase II to stabilize the transcription elongation machinery. This interaction is essential for maintaining the stability and function of the elongation process (Rayevsky2020Peptidyl).

The Spt4/Spt5 complex is characterized by a large β-sheet structure formed by antiparallel strands from each protein, creating a hydrophobic surface that facilitates protein-protein interactions. Key sequences from SUPT4H1 and SUPT5H, specifically "DGIIAM" and "KSVVA," respectively, are responsible for this interaction, contributing to the stability of the complex (Rayevsky2020Peptidyl).

In addition to its role in transcription elongation, SUPT4H1 has been implicated in the regulation of autophagy-related genes in yeast, where it forms part of a complex that negatively regulates the expression of ATG genes during active growth. This regulatory role is modulated by the phosphorylation of SUPT5H, which alters the complex's activity under autophagy-inducing conditions (Wen2019The).


## References


[1. (Park2022SUPT4H1edited) Hyun Jung Park, Areum Han, Ji Yeon Kim, Jiwoo Choi, Hee Sook Bae, Gyu-bon Cho, Hyejung Shin, Eun ji Shin, Kang-in Lee, Seokjoong Kim, Jae Young Lee, and Jihwan Song. Supt4h1-edited stem cell therapy rescues neuronal dysfunction in a mouse model for huntington’s disease. npj Regenerative Medicine, January 2022. URL: http://dx.doi.org/10.1038/s41536-021-00198-0, doi:10.1038/s41536-021-00198-0. This article has 13 citations.](https://doi.org/10.1038/s41536-021-00198-0)

[2. (Hentges2004Comparative) Kathryn E. Hentges, Mira Kytt�l�, Monica J. Justice, and Leena Peltonen. Comparative physical maps of the human and mouse meckel syndrome critical regions. Mammalian Genome, 15(4):252–264, April 2004. URL: http://dx.doi.org/10.1007/s00335-003-2303-y, doi:10.1007/s00335-003-2303-y. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00335-003-2303-y)

[3. (Wen2019The) Xin Wen, Damián Gatica, Zhangyuan Yin, Zehan Hu, Jörn Dengjel, and Daniel J. Klionsky. The transcription factor spt4-spt5 complex regulates the expression of atg8 and atg41. Autophagy, 16(7):1172–1185, September 2019. URL: http://dx.doi.org/10.1080/15548627.2019.1659573, doi:10.1080/15548627.2019.1659573. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1080/15548627.2019.1659573)

[4. (Rayevsky2020Peptidyl) Alexey Rayevsky, Maxim Platonov, Vasyl Hurmach, Anastasia Yakovenko, and Dmitriy Volochnyuk. Peptidyl inhibition of spt4‐spt5: protein‐protein inhibitors for targeting the transcriptional pathway related to c9orf72 expansion repeats. Journal of Cellular Biochemistry, 121(12):4922–4930, July 2020. URL: http://dx.doi.org/10.1002/jcb.29820, doi:10.1002/jcb.29820. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.29820)

[5. (Furuta2019Suppression) Natsumi Furuta, Setsuki Tsukagoshi, Kimitoshi Hirayanagi, and Yoshio Ikeda. Suppression of the yeast elongation factor spt4 ortholog reduces expanded sca36 ggccug repeat aggregation and cytotoxicity. Brain Research, 1711:29–40, May 2019. URL: http://dx.doi.org/10.1016/j.brainres.2018.12.045, doi:10.1016/j.brainres.2018.12.045. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.brainres.2018.12.045)